Presentation Information
[3-MO32-6]Development of177Lu-labeled albumin binder-conjugated radiopharmaceutical targeting FAP
Kosuke Saito1、Hiroyuki Watanabe1、Kazuma Nakashima1、Yusuke Chiba2、Kazuyuki Hashimoto2、Shunsuke Hujino2、Yukimasa Kawauchi3、Hideya Saeki3、Naoki Takashima3、Masako Kawabata3、Masahiro Ono1 (1.Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan、2.Japan Atomic Energy Agency, Ibaraki, Japan、3.Chiyoda Technol Corporation, Tokyo, Japan)